Stroke Was Third Most Common GBD Level 3 Cause of Death in 2021
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 20, 2024 -- The global burden of stroke is considerable, according to a study published in the October issue of The Lancet Neurology.
Valery L. Feigin, M.D., Ph.D., from the Auckland University of Technology in New Zealand, and colleagues estimated the incidence, prevalence, death, and disability-adjusted life-year (DALY) counts and age-standardized rates per 100,000 per year for stroke for 204 countries and territories from 1990 to 2021.
The researchers found that stroke was the third most common Global Burden of Disease (GBD) level 3 cause of death in 2021 (7.3 million deaths; 10.7 percent of all deaths), after ischemic heart disease and COVID-19. Stroke was the fourth most common cause of DALYs (160.5 million DALYs; 5.6 percent). There were 93.8 million prevalent and 11.9 million incident strokes in 2021. There were disparities observed in stroke burden and risk factors by GBD region, country or territory, and sociodemographic index; in addition, from 2015 onward, there was a stagnation in the reduction of incidence. Some increases in the stroke incidence, death, prevalence, and DALY rates were seen in specific regions and subpopulations. Substantial increases were seen in DALYs attributable to high body mass index, high ambient temperature, high fasting plasma glucose, diet high in sugar-sweetened beverages, low physical activity, high systolic blood pressure, lead exposure, and diet low in omega-6 polyunsaturated fatty acids.
"Our study findings continue to point out that currently used stroke prevention strategies are not sufficiently effective to halt, let alone reduce, the fast growing stroke burden," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Delirium Common Among Critically Ill Patients With Stroke
TUESDAY, July 8, 2025 -- More than one in four critically ill patients with stroke experience delirium, according to a study published online July 1 in the American Journal...
A-Fib Catheter Ablation Cuts Risk for Ischemic Stroke After 30 Days, Mortality, Heart Failure Hospitalization
MONDAY, July 7, 2025 -- For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and heart failure...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.